Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions

Christopher Poppe, Jan Christoph Bublitz, Dimitris Repantis

JAMA Psychiatry August 1, 2025 DOI: 10.1001/jamapsychiatry.2025.1457 (opens in new tab)

Study at a glance

AI-extracted from the abstract

Characteristics	Viewpoint Peer reviewed
Population	Persons with psychiatric conditions considering physician-assisted death
Key points	Psychedelic treatment may serve as life-preserving care for psychiatric patients before physician-assisted death.

Abstract

This Viewpoint describes the benefits of providing psychedelic treatment to persons with psychiatric conditions as life-preserving care before physician-assisted death.

Psychedelic therapy at the end of life: unexplored alternative to assisted suicide in the UK. The British journal of psychiatry : the journal of mental science July 14, 2026
Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care. Neuropharmacology September 15, 2022 69 citations
Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying AJOB Neuroscience April 3, 2023 11 citations
Psychedelic-assisted psychotherapy for existential suffering: Facilitating self-transcendence at the end of life. The International Journal of Transpersonal Studies March 18, 2022
Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care May 7, 2025

Study at a glance

Abstract

Related reading